Natco Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AVRO INDIA LIMITED with respect to announcement dated 25-Jan-2019, regarding Board meeting held on January 24, 2019. On basis of above the Company was required to clarify following: 1. Brief profile (in case of appointment) 2. Date of appointment/cessation (as applicable) & term of appointment. The response of the Company is attached.
Trident has issued commercial paper aggregating Rs 50 crore on 30 December 2021
Asian Paints Limited providing information regarding loss of share certificate by the shareholder(s) of the Company. Duplicate share certificate will be issued after completion of necessary procedures prescribed by Law. This information is being submitted pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
ACC Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Radico Khaitan Limited has informed the Exchange about Loss of Share Certificates
Zydus Cadilas US subsidiary Zydus Pharmaceuticals USA Inc has received tentative approval from the USFDA to market Pimavanserin Capsules in the strength of 34 mg USRLD Nuplazid Capsules Pimavanserin is an atypical antipsychotic and is indicated for the treatment of hallucinations and delusions associated with Parkinsons disease psychosis The drug will be manufactured at the groups formulation manufacturing facility at SEZ Ahmedabad The group now […]
Rane Brake Lining Limited has informed the Exchange regarding Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2021.
Prism Medico and Pharmacy announced that an Extra Ordinary General Meeting EGM of the Company will be held on 31 January 2022
The equity shares of Brandbucket Media Technology Scrip Code 543439 are listed and admitted to dealings on the Exchange in the list of MT Group Securities

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.